GlassScriptPhysician profile
Bonnie A Henderson
NPI 1710968953
$279,316.22
in general payments reported to CMS, 2019-2025
21 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89K · 2020: $30K · 2021: $32K · 2022: $43K · 2023: $58K · 2024: $27K · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $71K · Consulting Fee: $14K · Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $70,500.00 |
| Consulting Fee | $14,000.00 |
| Food and Beverage | $629.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $98,043.45 | 2022-2024 | Miebo, Lotemax Sm, Vyzulta |
| Alcon Vision LLC | $93,181.33 | 2019-2025 | Clareon, Argos |
| Alcon Research LLC | $41,018.57 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $25,873.04 | 2019 | |
| Allergan, INC. | $7,949.10 | 2019-2021 | |
| Horizon Therapeutics Plc | $5,481.31 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,574.07 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $1,500.00 | 2021 | |
| Eyepoint US, INC. | $1,316.82 | 2019 | |
| Kala Pharmaceuticals, INC. | $1,068.22 | 2019-2020 | |
| Dompe US, INC. | $821.12 | 2019-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $354.37 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $239.50 | 2019-2025 | Cequa |
| Sight Sciences, INC. | $234.83 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $177.26 | 2022-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $131.96 | 2019 | |
| Mallinckrodt Hospital Products INC. | $117.69 | 2020 | |
| Genentech USA, INC. | $117.13 | 2019 | |
| Oyster Point Pharma, INC. | $89.08 | 2022 | |
| Mallinckrodt Enterprises LLC | $14.84 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonnie Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.